Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK VAN WAMBEKE from Oudenaarde, company number BE0888222961, closed financial year 2025 with a result of € 15,151 after tax. For that financial year APOTHEEK VAN WAMBEKE recorded a gross margin of € 131,531 and equity of € 221,729. Compared with financial year 2024, the result moved from € 19,008 to € 15,151. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.
€ 221,729
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 15,151
▼ 20% vs 2024
Profit after tax over the fiscal year.
€ 4,582
▼ 87% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 175,729.
People and assets in 2025
1.1
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 87,590
▲ 12% vs 2024
€ 79,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 54,531
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 13,035
▼ 63% vs 2024
Loans from banks and other lenders, long and short.
€ 64,851
▼ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 13,736
▼ 16% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 119,465 | € 112,050 | € 128,306 | € 131,531 | ▲ 3% |
| Profit after taxes | € 13,096 | € 4,984 | € 19,008 | € 15,151 | ▼ 20% |
| Equity | € 182,586 | € 187,571 | € 206,579 | € 221,729 | ▲ 7% |
| Total debts | € 287,624 | € 298,284 | € 306,136 | € 276,627 | ▼ 10% |
| Cash | € 41,055 | € 16,532 | € 34,216 | € 4,582 | ▼ 87% |
| Retained profit | € 136,586 | € 141,571 | € 160,579 | € 175,729 | ▲ 9% |
| Bank debt | € 78,515 | € 56,976 | € 35,151 | € 13,035 | ▼ 63% |
| Balance sheet total | € 470,211 | € 485,855 | € 512,714 | € 498,356 | ▼ 3% |
| Employees (FTE) | 1.2 | 1.1 | 1 | 1.1 | ▲ 0.1 |
Key figures of APOTHEEK VAN WAMBEKE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to APOTHEEK VAN WAMBEKE?
What happened at APOTHEEK VAN WAMBEKE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 15,151 (▼ 20% vs 2024). Source: NBB ↗
- Marijke Van Wambeke became a director. NBB
- New establishment in Oudenaarde. KBO
- Start of the company according to the CBE. KBO
In short
From € 13,096 profit in 2022 to € 15,151 profit in 2025.
Paid € 26,298 in corporate taxes since 2022.
Best year ever: 2024, with € 19,008 profit.
On average € 119,600 of value added per employee in 2025.
A new publication or filing at APOTHEEK VAN WAMBEKE? We notify you, reason included.
Follow APOTHEEK VAN WAMBEKEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of HELEMA PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK VAN WAMBEKEBehind APOTHEEK VAN WAMBEKE are Helema Pharma BVBA and Marijke Van Wambeke. The shares are held by HELEMA PHARMA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Marijke Van Wambeke
since 2016
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Nederstraat 29
9700 Oudenaarde
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0888.222.961
- VAT number
- BE 0888.222.961
- Registered office
- Nederstraat 29, 9700 Oudenaarde
- Names & denominations
- APOTHEEK VAN WAMBEKE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 March 2007
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten